Minimally Invasive Surgical Instruments Market Size, Share, and Trends 2024 to 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Minimally Invasive Surgical Instruments Market 

5.1. COVID-19 Landscape: Minimally Invasive Surgical Instruments Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Minimally Invasive Surgical Instruments Market, By Device

8.1. Minimally Invasive Surgical Instruments Market, by Device, 2024-2033

8.1.1 Handheld Instruments

8.1.1.1. Market Revenue and Forecast (2021-2033)

8.1.2. Inflation Devices

8.1.2.1. Market Revenue and Forecast (2021-2033)

8.1.3. Surgical Scope

8.1.3.1. Market Revenue and Forecast (2021-2033)

8.1.4. Cutter Instruments

8.1.4.1. Market Revenue and Forecast (2021-2033)

8.1.5. Guiding Devices

8.1.5.1. Market Revenue and Forecast (2021-2033)

8.1.6. Electrosurgical Devices

8.1.6.1. Market Revenue and Forecast (2021-2033)

8.1.7. Auxiliary Devices

8.1.7.1. Market Revenue and Forecast (2021-2033)

8.1.8. Monitoring and Visualization Devices

8.1.8.1. Market Revenue and Forecast (2021-2033)

Chapter 9. Global Minimally Invasive Surgical Instruments Market, By Application

9.1. Minimally Invasive Surgical Instruments Market, by Application, 2024-2033

9.1.1. Cardiac

9.1.1.1. Market Revenue and Forecast (2021-2033)

9.1.2. Gastrointestinal

9.1.2.1. Market Revenue and Forecast (2021-2033)

9.1.3. Orthopedic

9.1.3.1. Market Revenue and Forecast (2021-2033)

9.1.4. Vascular

9.1.4.1. Market Revenue and Forecast (2021-2033)

9.1.5. Gynecological

9.1.5.1. Market Revenue and Forecast (2021-2033)

9.1.5. Urological

9.1.6.1. Market Revenue and Forecast (2021-2033)

9.1.6. Thoracic

9.1.7.1. Market Revenue and Forecast (2021-2033)

9.1.7. Cosmetic

9.1.8.1. Market Revenue and Forecast (2021-2033)

9.1.9. Dental

9.1.9.1. Market Revenue and Forecast (2021-2033)

9.1.10. Others

9.1.10.1. Market Revenue and Forecast (2021-2033)

Chapter 10. Global Minimally Invasive Surgical Instruments Market, By End Use 

10.1. Minimally Invasive Surgical Instruments Market, by End Use, 2024-2033

10.1.1. Hospitals

10.1.1.1. Market Revenue and Forecast (2021-2033)

10.1.2. Ambulatory Surgical Centers

10.1.2.1. Market Revenue and Forecast (2021-2033)

Chapter 11. Global Minimally Invasive Surgical Instruments Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Device (2021-2033)

11.1.2. Market Revenue and Forecast, by Application (2021-2033)

11.1.3. Market Revenue and Forecast, by End Use (2021-2033)

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Device (2021-2033)

11.1.4.2. Market Revenue and Forecast, by Application (2021-2033)

11.1.4.3. Market Revenue and Forecast, by End Use (2021-2033)

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Device (2021-2033)

11.1.5.2. Market Revenue and Forecast, by Application (2021-2033)

11.1.5.3. Market Revenue and Forecast, by End Use (2021-2033)

11.2. Europe

11.2.1. Market Revenue and Forecast, by Device (2021-2033)

11.2.2. Market Revenue and Forecast, by Application (2021-2033)

11.2.3. Market Revenue and Forecast, by End Use (2021-2033)

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Device (2021-2033)

11.2.4.2. Market Revenue and Forecast, by Application (2021-2033)

11.2.4.3. Market Revenue and Forecast, by End Use (2021-2033)

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Device (2021-2033)

11.2.5.2. Market Revenue and Forecast, by Application (2021-2033)

11.2.5.3. Market Revenue and Forecast, by End Use (2021-2033)

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Device (2021-2033)

11.2.6.2. Market Revenue and Forecast, by Application (2021-2033)

11.2.6.3. Market Revenue and Forecast, by End Use (2021-2033)

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Device (2021-2033)

11.2.7.2. Market Revenue and Forecast, by Application (2021-2033)

11.2.7.3. Market Revenue and Forecast, by End Use (2021-2033)

11.3. APAC

11.3.1. Market Revenue and Forecast, by Device (2021-2033)

11.3.2. Market Revenue and Forecast, by Application (2021-2033)

11.3.3. Market Revenue and Forecast, by End Use (2021-2033)

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Device (2021-2033)

11.3.4.2. Market Revenue and Forecast, by Application (2021-2033)

11.3.4.3. Market Revenue and Forecast, by End Use (2021-2033)

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Device (2021-2033)

11.3.5.2. Market Revenue and Forecast, by Application (2021-2033)

11.3.5.3. Market Revenue and Forecast, by End Use (2021-2033)

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Device (2021-2033)

11.3.6.2. Market Revenue and Forecast, by Application (2021-2033)

11.3.6.3. Market Revenue and Forecast, by End Use (2021-2033)

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Device (2021-2033)

11.3.7.2. Market Revenue and Forecast, by Application (2021-2033)

11.3.7.3. Market Revenue and Forecast, by End Use (2021-2033)

11.4. MEA

11.4.1. Market Revenue and Forecast, by Device (2021-2033)

11.4.2. Market Revenue and Forecast, by Application (2021-2033)

11.4.3. Market Revenue and Forecast, by End Use (2021-2033)

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Device (2021-2033)

11.4.4.2. Market Revenue and Forecast, by Application (2021-2033)

11.4.4.3. Market Revenue and Forecast, by End Use (2021-2033)

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Device (2021-2033)

11.4.5.2. Market Revenue and Forecast, by Application (2021-2033)

11.4.5.3. Market Revenue and Forecast, by End Use (2021-2033)

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Device (2021-2033)

11.4.6.2. Market Revenue and Forecast, by Application (2021-2033)

11.4.6.3. Market Revenue and Forecast, by End Use (2021-2033)

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Device (2021-2033)

11.4.7.2. Market Revenue and Forecast, by Application (2021-2033)

11.4.7.3. Market Revenue and Forecast, by End Use (2021-2033)

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Device (2021-2033)

11.5.2. Market Revenue and Forecast, by Application (2021-2033)

11.5.3. Market Revenue and Forecast, by End Use (2021-2033)

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Device (2021-2033)

11.5.4.2. Market Revenue and Forecast, by Application (2021-2033)

11.5.4.3. Market Revenue and Forecast, by End Use (2021-2033)

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Device (2021-2033)

11.5.5.2. Market Revenue and Forecast, by Application (2021-2033)

11.5.5.3. Market Revenue and Forecast, by End Use (2021-2033)

Chapter 12. Company Profiles

12.1. The Johns Hopkins Hospital

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Apollo Hospitals Enterprise Ltd.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. The General Hospital Corporation

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Bedfordshire Hospitals

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Stanford Healthcare

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. Circle Health Ltd.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. Singapore General Hospital Ltd.

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Manipal Health Enterprises Pvt. Ltd

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. Mount Elizabeth Hospital

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. King Fahd Medical City

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms